Registration is open for the South Texas Alzheimer’s Conference
February 21, 2023
The South Texas Alzheimer’s Conference Public Event, taking place on March 8, is open to all members of the community.
Alzheimer’s disease clinical trial seeks 21 area volunteers
January 31, 2023
Study will evaluate senolytics — drugs that clear defective ‘zombie’ cells A clinical trial conducted at UT Health San Antonio aims to “stomp” out Alzheimer’s disease. Clearing old, damaged “zombie” cells from the brain may be one way to do it. The study, called SToMP-AD (Senolytic Therapy to Modulate the Progression of Alzheimer’s Disease), seeks 21 San […]
The Center for Brain Health (Opening in 2024-25)
January 20, 2023
With more than 50 studies, departments and centers, the Center for Brain Health at The University of Texas Health Science Center at San Antonio will be home to the institution’s many brain health initiatives. It will include an imaging suite and a non-oncology infusion suite for patient care and clinical trials.
The Center for Brain Health (Opening in 2024-25)
January 19, 2023
Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu With more than 50 studies, departments and centers, the Center for Brain Health at The University of Texas Health Science Center at San Antonio will be home to the institution’s many brain health initiatives. For a complete overview of these vital programs, visit https://advancingbrainhealth.org/. Recently, UT Health San Antonio received […]
Art talk seeks to bring ‘ReCollections’ to families living with dementia
January 11, 2023
Kathleen Schock doesn’t claim to be an art expert. But in her elegantly comfortable home filled with her sister-in-law’s artwork, she points out a favorite piece as it reflects the afternoon sun, changing at every angle. She recalled that four years ago, Jim, her husband of 51 years, was diagnosed with dementia. But like […]
A new era in Alzheimer’s treatment
January 11, 2023
Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu Statement from the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio about a timely topic in the news: The U.S. Food and Drug Administration on Friday, Jan. 6, 2023, approved lecanemab, a drug that targets the basic pathophysiology of Alzheimer’s disease. The FDA action is […]
